Contribution of CYP3A4, CYP2B6, and CYP2C9 Isoforms to N-Demethylation of Ketamine in Human Liver Microsomes

2002/07/01 by Youssef Hijazi, Roselyne Boulieu · 8 citations
Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics · #Pharmacogenetics and Drug Metabolism #Treatment of Major Depression #Tryptophan and brain disorders

paper · doi:10.1124/dmd.30.7.853

crossref issued 2002/07/01 · crossref published 2002/07/01 · crossref published-print 2002/07/01 · openalex publication_date 2002/07/01 · crossref created 2003/01/15 · openalex created_date 2016/06/24 · crossref deposited 2025/02/18 · crossref indexed 2026/07/07 · openalex updated_date 2026/07/07

Cited by

• Administration of ketamine for unipolar and bipolar depression
• Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
• Ketamine*
• Classics in Chemical Neuroscience: Ketamine
• Ketamine: 50 Years of Modulating the Mind
• Ketamine for chronic pain: risks and benefits
• Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches
• Ketamine [wikipedia]